Tirzepatide, the recently approved medication, is sparking considerable excitement within the scientific community. It works differently from traditional diabetes medications, targeting multiple receptors involved in blood regulation and satiety. Initial research have demonstrated remarkable efficacy in controlling blood glucose in individuals with